Quarterly report pursuant to Section 13 or 15(d)

Related Party Matters (Detail Textuals)

v3.10.0.1
Related Party Matters (Detail Textuals) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 06, 2018
Apr. 01, 2017
Feb. 28, 2018
Jan. 31, 2018
Jan. 19, 2018
Dec. 28, 2017
Mar. 31, 2017
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Related Party Transaction [Line Items]                        
Common stock gross proceeds     $ 1,750,000 $ 1,500,000           $ 3,250,000    
Aggregate gross proceeds               $ 900,000   900,000    
Proceeds from convertible debt issuance                   400,000    
Convertible debt                       $ 235,000
Loss on extinguishment of debt                   (590,392)    
Amortization of convertible debt discount                   34,608    
Change in fair value of conversion rights of convertible debt                   185,000    
Accrued interest related to the convertible debt               3,767   3,767    
Independent contractor agreement | K2C, Inc.                        
Related Party Transaction [Line Items]                        
Monthly fee   $ 20,000         $ 10,000          
Total expense incurred under agreement               0 $ 60,000 220,000 $ 90,000  
Independent contractor agreement | Emerald Health Sciences Inc                        
Related Party Transaction [Line Items]                        
Total expense incurred under agreement               150,000   250,000    
Accrued and accounts payable - related party               50,000   $ 50,000    
Percentage of accrued interest on outstanding balance                   12.00%    
Separation and release agreement | K2C, Inc.                        
Related Party Transaction [Line Items]                        
Common stock gross proceeds     180,000                  
Recognized additional stock based compensation expense of restricted stock and option awards     $ 112,270                  
Separation and release agreement | K2C, Inc. | Immediate vesting                        
Related Party Transaction [Line Items]                        
Number of restricted common stock vested     900,000                  
Separation and release agreement | K2C, Inc. | October 20, 2015                        
Related Party Transaction [Line Items]                        
Number of restricted common stock vested     325,000                  
Separation and release agreement | K2C, Inc. | November 21, 2014                        
Related Party Transaction [Line Items]                        
Number of restricted common stock vested     125,000                  
Consulting Agreement | Emerald Health Sciences Inc                        
Related Party Transaction [Line Items]                        
Total expense incurred under agreement               15,000   $ 30,000    
Terms of agreement renewed 1 year                      
Accrued and accounts payable - related party               15,000   15,000    
Annual fee $ 60,000                      
Secured promissory note and security agreement | Emerald Health Sciences Inc | Bridge Loan                        
Related Party Transaction [Line Items]                        
Aggregate gross proceeds           $ 900,000            
Proceeds from convertible debt issuance         $ 500,000 500,000            
Funds received under the Secured Promissory Note         $ 400,000 400,000            
Convertible debt           265,000            
Increase in conversion liability           $ 360,000            
Initial conversion price         $ 0.10              
Shares converted into common stock         9,000,000              
Loss on extinguishment of debt                   590,392    
Amortization of convertible debt discount                   34,608    
Marked to market the conversion liabilities               $ 810,000   810,000    
Change in fair value of conversion rights of convertible debt                   $ 185,000